Pricing Log in Create free account
Friday 6 November 2026 Export ALC’s income statement to Excel — free account

Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

76.45 0.86 −1.11%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Alcon (ALC) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Alcon (ALC) trades at a EV/EBITDA of 14.8×. Over the past ten years it has ranged from 0.0× (June 2019) to 39.3× (December 2020); the current reading is higher than 10% of that period. That is in line with the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 16.5× (2.98%)
FY2024 17.0× (7.66%)
FY2023 18.4× (12.77%)
FY2022 21.1× (16.09%)
FY2021 25.1× (17.52%)
FY2020 30.4× 27.60%
FY2019 23.9× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.1× (16.18%)
Mar 2026 15.7× (4.82%)
Dec 2025 16.5× 7.51%
Sep 2025 15.3× (15.68%)
28 more quarters

Against its own ten years

Low 0.0× High 39.3×
Ten-year median 20.6×
Current reading's percentile 10

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.5×
SOLV Solventum Corporation compare 7.6×
ALGN Align Technology, Inc. compare 12.6×
BAX Baxter International Inc. compare 13.2×
ALC Alcon 14.8×
BDX Becton, Dickinson and Company compare 14.9×
RMD ResMed Inc. compare 15.7×
COO The Cooper Companies, Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. compare 28.4×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ALC